<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Evan Albright — Digest tagged &quot;fintech&quot;</title><description>Digest issues tagged #fintech.</description><link>https://www.evanalbright.com/</link><language>en-us</language><item><title>OpenAI model cracks an 80-year-old math problem as Lilly&apos;s obesity drug hits surgery-level results</title><link>https://www.evanalbright.com/digest/2026-05-21/</link><guid isPermaLink="true">https://www.evanalbright.com/digest/2026-05-21/</guid><description>An OpenAI reasoning model disproved an 80-year-old Erdős conjecture in discrete geometry for under $1,000 in compute, a result mathematicians are calling one of the most significant AI contributions to pure math to date. Eli Lilly&apos;s retatrutide, a triple-receptor obesity drug, produced bariatric-surgery-level weight loss in a Phase 3 trial, though dropout rates from side effects were notable. Google shipped Gemini 3.5 Flash to general availability at Google I/O and announced a $100 AI Ultra subscription tier. The acting head of NIH&apos;s infectious disease institute stepped down as senators pressed NIH Director Jay Bhattacharya on leadership gaps and a proposed 2027 budget cut. Kevin Warsh was confirmed and sworn in as the new Federal Reserve chair this week.</description><pubDate>Thu, 21 May 2026 00:00:00 GMT</pubDate><category>ai</category><category>pharma</category><category>economy</category><category>healthtech</category><category>software</category><category>llm</category><category>obesity</category><category>fed</category><category>nih</category><category>openai</category><category>google</category><category>gemini</category><category>mathematics</category><category>agents</category><category>clinical-trials</category><category>reasoning</category><category>evals</category><category>inference</category><category>models</category><category>products</category><category>ide</category><category>developer-tools</category><category>antigravity</category><category>datasette</category><category>open-source</category><category>python</category><category>spacex</category><category>infrastructure</category><category>training</category><category>compute</category><category>codex</category><category>engineering</category><category>gpt</category><category>productivity</category><category>workflow</category><category>tools</category><category>anthropic</category><category>cloud</category><category>security</category><category>enterprise</category><category>education</category><category>deployment</category><category>strategy</category><category>rag</category><category>embedding</category><category>retrieval</category><category>grok</category><category>nvidia</category><category>efficiency</category><category>ux</category><category>policy</category><category>access</category><category>partnership</category><category>compliance</category><category>safety</category><category>verification</category><category>synthetic-media</category><category>meta</category><category>layoffs</category><category>rust</category><category>systems</category><category>android</category><category>survey</category><category>language</category><category>macos</category><category>text-editor</category><category>agent</category><category>database</category><category>sandbox</category><category>visualization</category><category>model</category><category>tool</category><category>cost-tracking</category><category>design</category><category>glp-1</category><category>lilly</category><category>phase3</category><category>adc</category><category>oncology</category><category>lung-cancer</category><category>merck</category><category>niaid</category><category>leadership</category><category>public-health</category><category>senate</category><category>budget</category><category>medicare</category><category>fraud</category><category>insurance</category><category>doj</category><category>clinical-trial</category><category>biotech</category><category>geopolitics</category><category>pediatric</category><category>immunology</category><category>market</category><category>fda</category><category>wearable</category><category>media</category><category>publishing</category><category>ehr</category><category>privacy</category><category>surveillance</category><category>clinical</category><category>workforce</category><category>surgery</category><category>burnout</category><category>health-policy</category><category>wearables</category><category>blood-pressure</category><category>digital-health</category><category>regulation</category><category>pancreatic-cancer</category><category>kras</category><category>asco</category><category>telehealth</category><category>uspstf</category><category>monetary-policy</category><category>interest-rates</category><category>macro</category><category>capex</category><category>tech</category><category>investment</category><category>payments</category><category>fintech</category><category>research</category><category>labor</category><category>unions</category><category>wages</category><category>finance</category><category>demographics</category><category>behavior</category><category>science</category><category>psychology</category><category>decision-making</category><category>economics</category><category>bonds</category><category>smartphones</category><category>fertility</category><category>migration</category><category>remittances</category><category>developing-economies</category><category>space</category><category>innovation</category><category>markets</category></item><item><title>FDA loses two leaders in one week as Ebola outbreak draws WHO emergency declaration</title><link>https://www.evanalbright.com/digest/2026-05-17/</link><guid isPermaLink="true">https://www.evanalbright.com/digest/2026-05-17/</guid><description>The FDA&apos;s leadership vacuum deepened this week as the drug center head followed Commissioner Makary out the door, leaving the agency with no confirmed leadership at its two most critical posts. Open-weight models kept multiplying with Gemma 4, DeepSeek V4, and Kimi K2.6 all dropping in the same month, while Sebastian Raschka&apos;s analysis of new KV-sharing and compressed attention techniques explains why long-context costs are falling fast. A rare Bundibugyo Ebola outbreak in Congo&apos;s Ituri province prompted a WHO public health emergency declaration, and the WHO&apos;s move landed as hantavirus conspiracy theories were already cycling through social media. On the economy side, Trump&apos;s China visit produced mixed signals on decoupling, while Noah Smith argued that Europe&apos;s comfortable stagnation is no longer viable.</description><pubDate>Sun, 17 May 2026 00:00:00 GMT</pubDate><category>ai</category><category>software</category><category>pharma</category><category>healthtech</category><category>economy</category><category>fda</category><category>llm</category><category>open-source</category><category>ebola</category><category>trade</category><category>attention</category><category>inference</category><category>efficiency</category><category>evals</category><category>china</category><category>benchmarks</category><category>ecosystem</category><category>strategy</category><category>rl</category><category>self-play</category><category>reasoning</category><category>alphago</category><category>rlvr</category><category>science</category><category>research</category><category>scaling</category><category>ai-safety</category><category>forecasting</category><category>products</category><category>startups</category><category>productivity</category><category>operations</category><category>processes</category><category>pricing</category><category>enterprise</category><category>saas</category><category>gpt</category><category>agents</category><category>chatgpt</category><category>fintech</category><category>openai</category><category>product</category><category>policy</category><category>government</category><category>local-llm</category><category>apple-silicon</category><category>cost</category><category>pretraining</category><category>infrastructure</category><category>training</category><category>nvidia</category><category>models</category><category>deepseek</category><category>competition</category><category>anthropic</category><category>claude</category><category>design</category><category>tools</category><category>jobs</category><category>layoffs</category><category>industry</category><category>data</category><category>transformers</category><category>architecture</category><category>limitations</category><category>safety</category><category>datasette</category><category>plugins</category><category>cost-control</category><category>security</category><category>windows</category><category>cryptography</category><category>exploit</category><category>supply-chain</category><category>npm</category><category>macos</category><category>css</category><category>frontend</category><category>engineering</category><category>clickhouse</category><category>performance</category><category>databases</category><category>nhs</category><category>leadership</category><category>regulation</category><category>cder</category><category>opinion</category><category>who</category><category>outbreak</category><category>pheic</category><category>m&amp;a</category><category>biopharma</category><category>dealmaking</category><category>gene-therapy</category><category>rare-disease</category><category>nonprofit</category><category>marketplace</category><category>senate</category><category>health-policy</category><category>screening</category><category>mammography</category><category>evidence</category><category>guidelines</category><category>hantavirus</category><category>public-health</category><category>risk</category><category>takeda</category><category>compliance</category><category>settlement</category><category>ma</category><category>consolidation</category><category>340b</category><category>amgen</category><category>prostate</category><category>oncology</category><category>biotech</category><category>misinformation</category><category>virology</category><category>epidemiology</category><category>cancer</category><category>mifepristone</category><category>supreme-court</category><category>abortion</category><category>access</category><category>clinical-trials</category><category>early-detection</category><category>tariffs</category><category>geopolitics</category><category>decoupling</category><category>europe</category><category>gdp</category><category>inequality</category><category>growth</category><category>prediction-markets</category><category>finance</category><category>investor-relations</category><category>capital-markets</category><category>private-equity</category></item></channel></rss>